European Stroke Journal

European Stroke Journal (ESJ) is the peer-reviewed journal of the European Stroke Organisation, published by Oxford University Press, founded in 2016 and devoted to clinical stroke research across prevention, diagnosis, acute treatment and rehabilitation, with a 2025 Journal Impact Factor of 5.2.《欧洲卒中杂志》（European Stroke Journal，ESJ）是欧洲卒中组织（European Stroke Organisation）的同行评审期刊，由（Oxford University Press）出版，2016 年创刊，专注卒中预防、诊断、急性期治疗与康复的临床研究，2025 年期刊影响因子为 5.2。

Scope

• Clinical trials in acute stroke, covering intravenous thrombolysis, endovascular thrombectomy, neuroprotection and trial methodology.急性卒中的临床试验，涵盖静脉溶栓、血管内取栓、神经保护及试验方法学。
• Epidemiology, stroke burden and variation in outcome, drawing on registries, quality registers and population-based cohorts.流行病学、卒中疾病负担与结局差异，依托登记研究、质量登记库与人群队列。
• Primary and secondary prevention, including vascular risk factors, antithrombotic strategy, lifestyle intervention and health policy.一级与二级预防，包括血管危险因素、抗栓策略、生活方式干预与卫生政策。
• Diagnosis and imaging, from CT and MRI protocols to ultrasound, cardiac work-up and circulating biomarkers.诊断与影像，从 CT 与 MRI 方案到超声、心脏病因筛查及循环生物标志物。
• Acute and post-acute management, including stroke units, critical care, complication control and early secondary prevention.急性期与亚急性期管理，包括卒中单元、重症监护、并发症控制与早期二级预防。
• Rehabilitation, recovery and life after stroke, together with the organisation of stroke care and its societal impact.康复、功能恢复与卒中后生活，并涵盖卒中照护组织与社会影响。
• Guidelines, position papers and white papers issued by the European Stroke Organisation, which carry dedicated methodology and review.欧洲卒中组织发布的指南、立场文件与白皮书，均配有专门的方法学与评审流程。

History

• The journal was launched by the European Stroke Organisation in 2016, with Volume 1 appearing that year under SAGE of London.本刊由欧洲卒中组织于 2016 年创办，第 1 卷当年由伦敦的（SAGE）出版。
• One volume has been issued each year since, so Volume 11 covers 2026 and carries the October 2026 articles under DOIs beginning 10.1093.此后每年出版一卷，2026 年为第 11 卷，2026 年 10 月的论文已改用 10.1093 开头的（DOI）。
• From January 2026 the journal moved to Oxford University Press and became fully open access, ending its subscription model.自 2026 年 1 月起，本刊转由（Oxford University Press）出版并转为完全开放获取，订阅模式随之结束。
• It began as a quarterly and now appears monthly, with Volume 11 reaching its ninth issue in September 2026.创刊时为季刊，现已按月出版，第 11 卷在 2026 年 9 月已出至第 9 期。
• Supplement issues carry the society's guideline documents and themed collections alongside the regular research papers.增刊在常规研究论文之外，集中刊载学会的指南文件与专题文集。
• The 2025 Journal Impact Factor is 5.2 and CiteScore is 7.5, after 5.894 in 2022 and 4.5 in 2024, placing it in Q1 of clinical neurology.2025 年期刊影响因子为 5.2，CiteScore 为 7.5；此前 2022 年为 5.894，2024 年为 4.5，在临床神经病学类别位居 Q1。

Editors

• Kennedy R. Lees, professor of cerebrovascular medicine at the University of Glasgow, is editor-in-chief and leads an international editorial board.主编为格拉斯哥大学脑血管医学教授（Kennedy R. Lees），他领导一个国际化的编辑委员会。
• The board draws stroke neurologists, vascular physicians, trialists and methodologists from across Europe and beyond, reflecting the society's membership.编委会汇集欧洲及以外地区的卒中神经科医生、血管医学专家、临床试验者与方法学家，与学会会员构成相呼应。
• Manuscripts are submitted and tracked through ScholarOne, with article types including original research, reviews, white papers, study protocols and letters.稿件经（ScholarOne）投稿并跟踪处理，体裁包括原创研究、综述、白皮书、研究方案与读者来信。
• Every research paper is externally peer reviewed, while ESO guidelines pass through a separate guideline development and public consultation process.所有研究论文均送外部同行评审，欧洲卒中组织的指南则另经专门的指南制定与公开征询流程。
• For early-career researchers the journal offers guided reviewing, and for busy clinicians a streamlined submission format with reduced reporting burden.本刊为青年研究者提供带指导的评审训练，为工作繁忙的临床医生提供精简的投稿格式以减轻填报负担。
• Because the journal is fully open access, authors pay an article processing charge, which read-and-publish agreements with institutions and consortia can cover in full.由于全面开放获取，作者需支付文章处理费，与机构及联盟签订的阅读出版协议可全额承担该费用。